|
|
|
|
 |
 |

    |
As a Trial Management Organization (TMO) Interspond works to identify study opportunities for sites'
participation. We maintain a database of hundreds of qualified, experienced investigative sites
capable of conducting Phase I through Phase IV studies. These sites are located throughout the
country and are multi-therapeutic in nature.
Interspond differs from a Site Management Organization (SMO) in that we don't own the sites with
which we work and do not have exclusive arrangements with them.
Interspond provides added value to Sponsors and CROs by quickly identifying qualified sites for
participation. We then work closely with the Sponsors or CRO in executing a Confidentiality
Disclosure Agreement (CDA), facilitating the completion and submission of the Site Questionnaire,
assisting in the scheduling of a Pre-Study Site Visit (PSSV), overseeing the completion and
submission of the regulatory documents, and negotiating the contract and budget. We are ultimately
responsible for paying the sites the agreed upon budget.
|
|
|
|
|
|
|
|